Aeluma Business Summary

Aeluma, Inc. (ALMU) is a semiconductor technology company that generates revenue primarily through high-value research and development contracts with government agencies, including NASA and RFSUNY, while transitioning toward a commercial product-based model. The company specializes in a proprietary platform that integrates high-performance compound semiconductors with standard large-diameter silicon wafer manufacturing, targeting primary business segments in AI data center interconnects, mobile sensing, and defense photonics. Aeluma competes directly with specialized semiconductor and photonics firms such as POET Technologies, indie Semiconductor, and Aehr Test Systems. Within this landscape, Aeluma positions itself as a high-growth disruptor, leveraging its unique ability to scale complex photonic-electronic integration for mass-market microelectronics, a capability reflected in its premium price-to-sales valuation relative to the broader industry. The company is led by Founder and CEO Dr. Jonathan Klamkin, a Professor of Electrical and Computer Engineering at UC Santa Barbara with a pedigree that includes roles at MIT Lincoln Laboratory and BinOptics (acquired by MACOM). The executive team was recently strengthened by the appointments of CFO Christopher Stewart, formerly of LeddarTech and Bionano Genomics, and Senior VP of Business Development Bouchaib Nessar, a 30-year industry veteran from Lumentum and SCD.USA. Aeluma’s technical direction is overseen by Director of Technology Dr. Matthew Dummer, previously a principal scientist at Vixar (acquired by ams-OSRAM). The Board of Directors features notable industry figures, including Michael J. Byron, a former long-time Vice President of Finance at NVIDIA, and Dr. Steven DenBaars, a prolific entrepreneur and co-founder of Nitres (acquired by Cree) and SLD Laser (acquired by Kyocera).